Iradimed reports record Q4 revenue $22.7M, EPS $0.50; raises dividend to $0.20

IRADIMED CORP

2025-FY EPS reported $1.75 revenue$83,814,000

Q4 2025 revenue $22.7M (+17% YoY); GAAP diluted EPS $0.50 (+25%), non-GAAP $0.54 (+23%).
Full year 2025 revenue $83.8M (+14% YoY); GAAP diluted EPS $1.75 (+17%), non-GAAP $1.93 (+16%).
Quarterly dividend raised 18% to $0.20/share from $0.17, payable March 6, 2026 to holders of record Feb 23.
FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.06-2.21.
Initial 3870 next-gen MRI pump shipped in Q4; full rollout begins Q1 2026 with meaningful H2 revenue contribution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.